While the healthcare industry as a whole is taking steps to become more patient-centric, pharmaceutical companies are beginning to incorporate patient-focused strategies to improve clinical trial design, boost patient enrollment, and drive down treatment costs and study timelines. To help clinical trials adopt a foundation that values patient input—and, ultimately, improves patient outcomes—drug developers need to view trial participants as strategic partners instead of research subjects. The key is to engage patients during the early stages of the drug development process, establish a strong connection and maintain the relationship throughout the clinical trial and beyond.
In this e-book, ZS experts share a four-pillar framework designed to help life sciences companies put patients at the center of all drug development activities
